Skip to main content
Premium Trial:

Request an Annual Quote

Mt. Sinai, Exosome Ink Deal for Body Fluid MDx

NEW YORK (GenomeWeb News) – The Icahn School of Medicine at Mount Sinai and Exosome Diagnostics today announced a collaboration to research and develop nucleic acid-based body fluid diagnostics.

As part of the five-year deal, Exosome will provide technical and development support to Mt. Sinai researchers, as well as early access to technology product upgrades. Mt. Sinai retains rights to molecular biomarkers associated with disease progression and drug response, while Exosome will retain commercial development rights for molecular in vitro diagnostic products. Further details were not disclosed.

Exosome and Mt. Sinai plan to create targeted research and biomarker discovery programs in oncology, inflammation, and other disease areas, they said. New York-based Exosome anticipates it will pursue commercial development and US Food and Drug Administration review of successful validations for in vitro diagnostics.

"As we advance our precise medicine program in the Departments of Pathology and Genomics at Mount Sinai, biofluid-based, point-in-time analyses, made possible by the Exosome Diagnostics-Mount Sinai relationship, will undoubtedly lead to an improved, patient-centric understanding of disease, thereby guiding more informed treatment decisions and response to therapy," Carlos Cordon-Cardo, chairman of the department of pathology at the Icahn School of Medicine and a member of Exosome's scientific advisory board, said in a statement.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.